C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
11/2006
11/02/2006	WO2006076455A8 Processes for preparing pyrazolo[3,4-d]pyrimidine ethers
11/02/2006	WO2006066818A3 7-AMINO-6-HETARYL-1,2,4-TRIAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AND THE USE THEREOF FOR CONTROLLING PATHOGENIC FUNGI
11/02/2006	WO2006061392A3 Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives
11/02/2006	WO2006033007A3 Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one
11/02/2006	US20060247294 angiogenesis inhibitors; as antitumor agents; kinase inhibitors like vascular endothelial growth factor receptors antagonists
11/02/2006	US20060247289 Certain chemical entities, compositions, and methods
11/02/2006	US20060247270 3-Substituted-2(Arylalkyl)-1-Azabicycloalkanes and Methods of Use Thereof
11/02/2006	US20060247259 Urea derivatives containing aromatic or heteroaromatic rings; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide; prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
11/02/2006	US20060247251 2-Cyanopyrrolopyrimidines and pharmaceutical uses thereof
11/02/2006	US20060247245 Substituted imidazolopyrazine and triazolopyrazine derivatives: gabaa receptor ligands
11/02/2006	US20060247237 Macrocyclic quinazoline derivatives as antiproliferative agents
11/02/2006	US20060246534 Method for extending light-emitting time of calcium-binding photoprotein solution
11/02/2006	US20060246482 Linker molecules for selective metallisation of nucleic acids and their uses
11/02/2006	US20060246023 Solvent-free process for the preparation of diketopyrrolopyrrole derivatives
11/02/2006	US20060246012 Delivery of physiologically active compounds through an inhalation route
11/02/2006	US20060246011 Delivery of diphenhydramine through an inhalation route
11/02/2006	EP1717239A1 Substituted sym-triindole
11/02/2006	EP1717230A1 Fused-ring 4-oxopyrimidine derivative
11/02/2006	EP1716601A1 Organic thin film transistor
11/02/2006	EP1716153A2 Methods, compositions, and apparatuses for forming macrocyclic compounds
11/02/2006	EP1716152A2 Fused hetrocyclic compounds and their use as metabotropic receptor antagonists for the treatment of gastrointestinal disorders
11/02/2006	EP1716151A1 Compositions useful as inhibitors of protein kinases
11/02/2006	EP1716150A2 Substituted heterocyclic compounds and methods of use
11/02/2006	EP1716125A1 Tetrazole compounds and their use as metabotropic glutamate receptor antagonits
11/02/2006	EP1202976B1 Pyrazinones, compositions containing such compounds
11/02/2006	EP1192133B1 N-cyclopentyl modulators of chemokine receptor activity
11/02/2006	EP1003721B1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
11/02/2006	EP0885883B1 Fused heterocyclic compounds and pharmaceutical applications thereof
11/02/2006	CA2605603A1 Ortho-terphenyl inhibitors of p38 kinase and methods of treating inflammatory disorders
11/02/2006	CA2605262A1 Phenylacetylene derivatives having mglur5 receptor affinity
11/02/2006	CA2604284A1 Protein kinase inhibitors
11/02/2006	CA2599419A1 Dipeptidyl peptidase-iv inhibitors
11/01/2006	CN1856572A Use of RNAi inhibiting parp activtiy for the manufacture of a medicament for the treatment of cancer
11/01/2006	CN1856547A Fluorinated dyes or colorants and their uses
11/01/2006	CN1856313A Therapeutic compounds
11/01/2006	CN1856311A 6-aryl-7-halo-imidazo[1,2-A]pyrimidines as anticancer agents
11/01/2006	CN1856310A 喹唑啉钾通道抑制剂 Quinazoline potassium channel inhibitors
11/01/2006	CN1854138A 3,7-diazabicyclo[3.3.0]octanes and their use in the treatment of cardiac arrhythmias
11/01/2006	CN1854137A Method for resoluting zopiclone
10/2006
10/31/2006	US7129356 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
10/31/2006	US7129351 Pyrimido compounds having antiproliferative activity
10/31/2006	US7129348 Such as heaxnitrohexaazaisowurtzitane; hydrogenolysis; acetylation; nitration; propellants; explosives
10/31/2006	US7129261 Cytotoxic agents
10/31/2006	US7129253 Compounds
10/31/2006	US7129244 Triazolopyrimidines and related analogs as HSP90-inhibitors
10/31/2006	US7129242 Such as 4-((4-chlorophenyl)pyrimidin-2-yl)amino)benzamide; for treatment of inflammation/autoimmune conditions
10/31/2006	US7129237 5HT2c agonists or partial agonists; e.g., 4,5,6,7,9a,10,11,12,13,13a-decahydro-9H-(1,4)diazepino-(6,7,1 -de)phenanthridine hydrochloride
10/31/2006	US7129235 Amides useful for treating pain
10/31/2006	CA2350560C Novel type condensed pyridazinone compounds
10/31/2006	CA2256545C Probe for analysis of nucleic acids
10/31/2006	CA2247419C Oxazole derivatives, their production and use
10/26/2006	WO2006113875A2 2 - pyrrolidone derivatives and their uses for the treatment of inflammatory conditions and pain
10/26/2006	WO2006113682A1 Process for preparing salts of 4-[[5-[(cyclopropylamino)carbonyl]-2-methylphenyl]amino]-5-methyl-n-propylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide and novel stable forms produced therein
10/26/2006	WO2006113150A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment
10/26/2006	WO2006112379A1 Drug for treating or diagnosing vascular lesion in the skin or the subcutaneous soft tissue caused by light irradiation
10/26/2006	WO2006111849A1 Acylaminobicyclic heteromatic compounds as cannabinoid receptor ligands
10/26/2006	WO2006111648A1 H-pyrimido[4,5-b]indole derivatives, their preparation and therapeutic use
10/26/2006	WO2006083271A3 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
10/26/2006	WO2006065448A3 Topoisomerase inhibitors and prodrugs
10/26/2006	WO2006036941A3 Specific kinase inhibitors
10/26/2006	WO2005095384A8 Pyrazine derivatives and pharmaceutical use thereof as adenosine antagonists
10/26/2006	US20060241171 Novel physiologically active substances
10/26/2006	US20060241166 Sapphyrins and uses thereof
10/26/2006	US20060241155 TNF-alpha production inhibitors
10/26/2006	US20060241131 Pyrrolo[2,3-d]pyrimidine compounds
10/26/2006	US20060241128 Substituted 6-(2-halogennphenyl)-triazolopyrimidines
10/26/2006	US20060241127 N-[2-Amino-6-(4-pyridinyl)-4-pyrimidinyl]-N-[2-fluoro-4-(1H-pyrrolo[2,3-b]-pyridin-4-yloxy)phenyl]amine, used for the treatment and/or prophylaxis of cardiovascular diseases and erectile dysfunction
10/26/2006	US20060241126 Phospholipase inhibitors perticularly phospholipase A2 enzyme Lipoprotein Associated Phospholipase A2; N-(1-Methylpiperidin-4-yl)-(2-(2-(2,3-difluorophenyl)ethyl)-4-oxo-4H-pyrido[2,3-d]pyrimidin-1-yl)-N-(4-(4-trifluoromethylphenyl)phenyl)methylacetamide; amidation
10/26/2006	US20060241116 affinity for peripheral-type benzodiazepine receptors; in vitro and in vivo affinity; chemical intermediates
10/26/2006	US20060241115 2,3-Dihydro-4H-1,4-benzoxazine derivatives containing an optionally fused pyridine or pyrimidine ring; 7-((6,7-bis(methyloxy)-4-quinolinyl)oxy)-N-phenyl-2,3-dihydro-4H-1,4-benzoxazine-4-carboxamide; kinase inhibitors; inflammation, angiogenesis and cancer
10/26/2006	US20060241100 Acylaminobicyclic heteroaromatic compounds and uses thereof
10/26/2006	US20060241095 complex comprising manganese acetate and {[{(Porphine-5,15-diyl)bis[cyclopropyl-diyl]}](2-)-N21,N22,N23, N24 }; reduce damage to cells; preventing or arresting free radical associated diseases or conditions; free radical scavengers
10/26/2006	US20060239936 Delivery of anti-migraine compounds through an inhalation route
10/26/2006	US20060236893 Photoreceptors
10/26/2006	DE10163667B4 Verwendung von Desoxypeganin zur Behandlung der klinischen Depression Use of deoxypeganine for the treatment of clinical depression
10/26/2006	CA2605479A1 Acylaminobicyclic heteroaromatic compounds and uses thereof
10/26/2006	CA2605075A1 2 - pyrrolidone derivatives and their uses for the treatment of inflammatory conditions and pain
10/26/2006	CA2603757A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment
10/25/2006	EP1714331A2 Phthalocyanine derivatives, their use as homeotropically aligned layer in electronic devices and method for the manufacturing thereof
10/25/2006	EP1713823A2 Hcv ns-3 serine protease inhibitors
10/25/2006	EP1713822A2 Hcv ns-3 serine protease inhibitors
10/25/2006	EP1713811A1 Use of phthalocyanines as marking substances for liquids
10/25/2006	EP1713810A1 Diazabicyclic aryl derivatives as nicotinic acetylcholine receptor ligands
10/25/2006	EP1713809A1 Dimeric azacyclic compounds and their use
10/25/2006	EP1713808A1 Two-phase method for the synthesis of selected pyrazolopyrimidines
10/25/2006	EP1713806A1 Compounds and compositions as protein kinase inhibitors
10/25/2006	EP1713802A1 2,4-dioxopyrimidine-based mesoionic pigments
10/25/2006	EP1713784A1 Imidazo-pyridazines, triazolo-pyridazines and related benzodiazepine receptor ligands
10/25/2006	EP1713484A2 Compounds and methods of use
10/25/2006	EP1560830B1 Derivatives of [6, 7-dihydro-5h-imidazo[1,2 - a]imidazole -3 -sulfonylamino]-propionamide and their use as inhibitors upon the interaction of cams and leukointegrins
10/25/2006	EP1554272B1 Benzimidazoles and benzothiazoles as inhibitors of map kinase
10/25/2006	EP1532152B1 Novel polymorph of n-methyl-n-(3- 3- 2-thienylcarbonyl\|-pyrazol- 1,5-alpha\|-pyrimidin-7-yl phenyl)acetamide and compositions and methods related thereto
10/25/2006	EP1517909B1 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
10/25/2006	EP1392689B1 Tri- and tetraaza-acenaphthylen derivatives as crf receptor antagonists
10/25/2006	CN1852897A Gabanergic modulators
10/25/2006	CN1852748A Azepine derivatives as pharmaceutical agents
10/25/2006	CN1852712A Dual NK1/NK3 antagonists for treating schizophrenia
10/25/2006	CN1281608C New azo-indolyl derivatives
10/25/2006	CN1281607C Quaternary ammonium salt compound of piperazine with pain relieving effect
10/25/2006	CN1281606C Nitrogen-containing heterocyclic compound

1 ... 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 ... 573